Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
暂无分享,去创建一个
[1] M. Savary,et al. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. , 1975, The Journal of thoracic and cardiovascular surgery.
[2] F. Ellis,et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. , 1978, American journal of clinical pathology.
[3] R. Riddell. Dysplasia in inflammatory bowel disease. , 1980, Clinics in gastroenterology.
[4] D. Skinner,et al. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. , 1983, Archives of surgery.
[5] D. Skinner,et al. Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.
[6] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[7] J. Boitnott,et al. The spectrum of carcinoma arising in Barrett's esophagus: A clinicopathologic study of 26 patients , 1984, The American journal of surgical pathology.
[8] J. Rosenberg,et al. Analysis of adenocarcinoma in barrett's esophagus utilizing a staging system , 1985, Cancer.
[9] S. Spechler,et al. Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. , 1986, Gastroenterology.
[10] B. Reid,et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.
[11] R. Jensen,et al. Famotidine: effective treatment of Zollinger-Ellison syndrome. , 1987, Journal of clinical gastroenterology.
[12] W. Macdonald,et al. Adenocarcinoma of the Esophagus and/or Gastric Cardia , 1987, Cancer.
[13] C. Winters,et al. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. , 1987, Gastrointestinal endoscopy.
[14] S. McClave,et al. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. , 1987, Gastrointestinal endoscopy.
[15] C. Winters,et al. Esophageal acid sensitivity in Barrett's esophagus. , 1987, Journal of clinical gastroenterology.
[16] D. Grueneberg,et al. DNA content in Barrett's esophagus and esophageal malignancy. , 1987, The American journal of gastroenterology.
[17] R. Sampliner,et al. Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia. , 1988, Gastroenterology.
[18] R. R. Smith,et al. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. , 1988, Human pathology.
[19] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.
[20] J. Mayberry,et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.
[21] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[22] R. Hunt,et al. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. , 1989, Gastrointestinal endoscopy.
[23] R. Sampliner,et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. , 1989, Gastroenterology.
[24] Richard L. Abbott,et al. A Follow-up Study , 1990 .
[25] D J Ballard,et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.
[26] A. Zinsmeister,et al. Prevalence of columnar-lined (Barrett's) esophagus , 1990 .
[27] N. Walker,et al. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. , 1991, Gut.
[28] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.
[29] B. Reid,et al. Endoscopic biopsy technique for acquiring larger mucosal samples. , 1991, Gastrointestinal endoscopy.
[30] P. Blount,et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. , 1992, Gastroenterology.
[31] S. Spechler. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. , 1992, The New England journal of medicine.
[32] D. Hopwood,et al. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. , 1992, Scandinavian journal of gastroenterology.
[33] P. Blount,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.
[34] D. Lane,et al. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. , 1992, Gastroenterology.
[35] Patricia L. Blount,et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.
[36] A R Zinsmeister,et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.
[37] W. Samowitz,et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. , 1993, Gastroenterology.
[38] T. Demeester,et al. Functional foregut abnormalities in Barrett's esophagus. , 1993, The Journal of thoracic and cardiovascular surgery.
[39] F. Ellis,et al. Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.
[40] R. Lebovitz,et al. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.
[41] D. Katzka,et al. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. , 1994, The American journal of gastroenterology.
[42] C. Lightdale,et al. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. , 1994, Gastrointestinal endoscopy.
[43] J. Peters,et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? , 1994, Archives of surgery.
[44] Carissa A. Sanchez,et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. , 1994, Gastroenterology.
[45] T. Hennessy,et al. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa , 1994, The British journal of surgery.
[46] P. Stevens,et al. Hypertensive emergency and ventricular tachycardia after endoscopic epinephrine injection of a Mallory-Weiss tear. , 1994, Gastrointestinal endoscopy.
[47] R. Goyal,et al. Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.
[48] J. Peters,et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.
[49] S. Steinberg,et al. Expansion of the Ki‐67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagus , 1995, Cancer.
[50] Treatment of Barrett's metaplasia by antireflux surgery and endoscopic laser ablation: Clinical experience in ten patients , 1995 .
[51] G. Meyer,et al. Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease , 1995 .
[52] J. Pignon,et al. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. , 1995, The American journal of surgical pathology.
[53] J. Freston,et al. Critical issues in the management of gastroesophageal reflux disease. , 1995, European journal of gastroenterology & hepatology.
[54] D. Castell,et al. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. , 1995, Archives of internal medicine.
[55] J. Jankowski,et al. Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables , 1995, International journal of cancer.
[56] A. Cameron,et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. , 1995, Gastroenterology.
[57] M. Johnston,et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. , 1996, The American journal of gastroenterology.
[58] R. Sampliner,et al. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. , 1996, Gastrointestinal endoscopy.
[59] M. Sivak,et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. , 1996, Gastrointestinal endoscopy.
[60] R. Heitmiller,et al. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.
[61] L. Laine,et al. Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. , 1996, Gastrointestinal endoscopy.
[62] J. Richardson,et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. , 1996, Annals of surgery.
[63] G. Lapertosa,et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. , 1996, Gastrointestinal endoscopy.
[64] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus: clinical update. , 1996, The American journal of gastroenterology.
[65] R. Cherian,et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. , 1996, The American journal of gastroenterology.
[66] Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1996 .
[67] J. Richter,et al. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. , 1996, Gastroenterology.
[68] A. Bhattacharyya,et al. Intestinal metaplasia of the gastric cardia. , 1997, The American journal of gastroenterology.
[69] A. Bhattacharyya,et al. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. , 1997, The American journal of gastroenterology.
[70] S. Re,et al. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997 .
[71] P. Schneider,et al. Early adenocarcinoma in Barrett's oesophagus , 1997, The British journal of surgery.
[72] R. Sandler,et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.
[73] Temporary left external axillofemoral bypass during repair of a leaking type B aortic dissection , 1997, The British journal of surgery.
[74] H. Garewal,et al. Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium. , 1997, The American journal of gastroenterology.
[75] M. Helfand,et al. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.
[76] R. Sampliner,et al. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. , 1997, The American journal of gastroenterology.
[77] S. Merigliano,et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). , 1997, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[78] M. Gammon,et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[79] A. Cameron. Management of Barrett's esophagus. , 1998, Mayo Clinic proceedings.
[80] P. Aló,et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. , 1998, Cytometry.
[81] Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus , 1998 .
[82] G. Tytgat,et al. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.
[83] R. Sampliner,et al. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.
[84] N. Dubin,et al. Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[85] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[86] S. Meltzer,et al. Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1 , 2006 .
[87] J. Byrne,et al. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation , 1998, American Journal of Gastroenterology.
[88] J. Hunter,et al. Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. , 1999, American journal of surgery.
[89] R. Fitzgerald,et al. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. , 1999, Gastroenterology.
[90] N. Powe,et al. Management of Barrett's esophagus: a national study of practice patterns and their cost implications , 1999, American Journal of Gastroenterology.
[91] K. Schrör,et al. Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.
[92] N. Talley,et al. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. , 1999, Gastrointestinal endoscopy.
[93] C. Begg,et al. impact of Hospital Volume on Operative Mortality for Major Cancer Surgery , 1999 .
[94] D. Castell,et al. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease , 1999, American Journal of Gastroenterology.
[95] E. Kuipers,et al. Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study , 1999, Gut.
[96] J H Peters,et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. , 1999, Annals of surgery.
[98] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[99] U. Ladabaum,et al. Barrett's Esophagus with High-Grade Dysplasia , 1999 .
[100] R. Wong,et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.
[101] The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999 .
[102] N. Powe,et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.
[103] Patricia L. Blount,et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[104] J. Goldblum,et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.
[105] G. Falk,et al. Practice patterns for surveillance of Barrett's esophagus in the united states. , 2000, Gastrointestinal endoscopy.
[106] P. Schauer,et al. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. , 2000, Surgery.
[107] L. Bonavina,et al. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus , 2002, Surgical Endoscopy And Other Interventional Techniques.
[108] Patricia L. Blount,et al. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables , 2001, American Journal of Gastroenterology.
[109] J. Peters,et al. Long-Term Outcome of Antireflux Surgery in Patients With Barrett’s Esophagus , 2001, Annals of surgery.
[110] M. Feith,et al. Preoperative chemotherapy unmasks underlying Barrett’s mucosa in patients with adenocarcinoma of the distal esophagus , 2002, Surgical Endoscopy.
[111] M. Guelrud,et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.
[112] Robert Edson,et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux , 2001, American Journal of Gastroenterology.
[113] Dennis M. Riehle,et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.
[114] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[115] K. Badizadegan,et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. , 2001, Gastroenterology.
[116] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[117] Carissa A. Sanchez,et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression , 2001, American Journal of Gastroenterology.
[118] Noel S Weiss,et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.
[119] J. Peters,et al. Vagal-Sparing Esophagectomy: A More Physiologic Alternative , 2002, Annals of surgery.
[120] G. Lapertosa,et al. Risk factors for Barrett's esophagus: A case‐control study , 2002, International journal of cancer.
[121] L. Brown,et al. Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.
[122] Kenneth K Wang,et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.
[123] M. Ferguson,et al. Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients , 2002, Journal of Gastrointestinal Surgery.
[124] H. El‐Serag,et al. Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? , 2003, American Journal of Gastroenterology.
[125] K. Ragunath,et al. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. , 2003, Endoscopy.
[126] G. Cooper. Endoscopic screening and surveillance for Barrett's esophagus: can claims data determine its effectiveness? , 2003, Gastrointestinal endoscopy.
[127] R. Sampliner,et al. Endoscopic Surveillance of Columnar-Lined Esophagus: Frequency of Intestinal Metaplasia Detection and Impact of Antireflux Surgery , 2003, American Journal of Gastroenterology.
[128] K. Kerlikowske,et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.
[129] A. Bhattacharyya,et al. Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.
[130] E. Steyerberg,et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial , 2004, Gut.
[131] R. Cherian,et al. Prospective Evaluation of Intestinal Metaplasia and Dysplasia Within the Cardia of Patients with Barrett's Esophagus , 1997, Digestive Diseases and Sciences.
[132] J. Goldblum,et al. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study. , 2004, Gastrointestinal endoscopy.
[133] J. Hunter,et al. Significance of Intestinal Metaplasia in Different Areas of Esophagus Including Esophagogastric Junction , 1997, Digestive Diseases and Sciences.
[134] Janusz Jankowski,et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.
[135] H. Sue-Ling,et al. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer , 2004, The British journal of surgery.
[136] S. DeMeester,et al. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. , 2004, The Annals of thoracic surgery.
[137] M. Mayo,et al. Yield of Intestinal Metaplasia in Patients with Suspected Short-Segment Barrett's Esophagus (SSBE) on Repeat Endoscopy , 2002, Digestive Diseases and Sciences.
[138] Carissa A. Sanchez,et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. , 2005, The Lancet. Oncology.
[139] H. Welch,et al. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.
[140] N. Shaheen,et al. Effect of a New Diagnosis of Barrett's Esophagus on Insurance Status , 2005, The American Journal of Gastroenterology.
[141] H. El‐Serag,et al. Abdominal Obesity and the Risk of Barrett's Esophagus , 2005, The American Journal of Gastroenterology.
[142] W. Hop,et al. The Incidence of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Barrett's Esophagus Makes a Difference , 2005, The American Journal of Gastroenterology.
[143] Michael Vieth,et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.
[144] J. Horwhat,et al. Cryoablation of Barrett's esophagus: a pilot study. , 2005, Gastrointestinal endoscopy.
[145] A. Ippoliti,et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. , 2005, Gastrointestinal endoscopy.
[146] D. Castell,et al. Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease , 1999, The American Journal of Gastroenterology.
[147] G. Chejfec,et al. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus , 2005, Digestive Diseases and Sciences.
[148] L. Gossner,et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.
[149] R. Kiesslich,et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[150] Kenneth K Wang,et al. The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus. , 2006, The Journal of molecular diagnostics : JMD.
[151] A. Axon,et al. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.
[152] Fumiaki Sato,et al. CpG island hypermethylation in progression of esophageal and gastric cancer , 2006, Cancer.
[153] P. Bampton,et al. Improving surveillance for Barrett's oesophagus , 2006, BMJ : British Medical Journal.
[154] A. Bansal,et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.
[155] R. Sampliner,et al. A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results , 2006, Gut.
[156] J. Hagen,et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. , 2006, Journal of the American College of Surgeons.
[157] A. Rastogi,et al. Detection of Barrett's Esophagus After Endoscopic Healing of Erosive Esophagitis , 2000, The American Journal of Gastroenterology.
[158] R. Sampliner,et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[159] Michael Vieth,et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.
[160] K. Yao,et al. Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging , 2007, Alimentary pharmacology & therapeutics.
[161] A. Csendes,et al. Adenocarcinoma Appearing very late after antireflux surgery for barrett’s esophagus: long-term follow-up, review of the literature, and addition of six patients , 2004, Journal of Gastrointestinal Surgery.
[162] Mari Mino-Kenudson,et al. Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. , 2007, Gastrointestinal endoscopy.
[163] C. Yeo,et al. Barrett’s esophagus with high grade dysplasia: Surgical results and long-term outcome— An update , 2003, Journal of Gastrointestinal Surgery.
[164] 郷田 憲一. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma , 2007 .
[165] Fred S. Drennan,et al. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. , 2006, Gastrointestinal endoscopy.
[166] Kenneth K Wang,et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.
[167] A. Shar,et al. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. , 2007, Journal of the National Cancer Institute.
[168] A. Noffsinger,et al. Narrow band imaging directed EMR for Barrett's esophagus with high-grade dysplasia. , 2007, Gastrointestinal endoscopy.
[169] J. Luketich,et al. Minimally invasive resection and mechanical cervical esophagogastric anastomotic techniques in the management of esophageal cancer , 2004, Journal of Gastrointestinal Surgery.
[170] Keith Abrams,et al. Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.
[171] Fernando Ramos,et al. A Randomized Comparison of Methylene Blue-Directed Biopsy Versus Conventional Four-Quadrant Biopsy for the Detection of Intestinal Metaplasia and Dysplasia in Patients With Long-Segment Barrett's Esophagus , 2008, The American Journal of Gastroenterology.